Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model

Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis

(2009) Heather Basciano et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

LXRα activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins

(2009) Heather Basciano et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Both the Peroxisome Proliferator-Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL-Derived Cholesterol

(2009) François Briand et al.   CTS-Clinical and Translational Science

Activation of the Liver X Receptor Stimulates Trans-intestinal Excretion of Plasma Cholesterol

(2009) Jelske N. van der Veen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse

(2009) Elaine M. Quinet et al.   JOURNAL OF LIPID RESEARCH

LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor

(2009) Noam Zelcer et al.   SCIENCE

Cholesterol Absorption From the Intestine Is a Major Determinant of Reverse Cholesterol Transport From Peripheral Tissue Macrophages

(2008) Ephraim Sehayek et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Postprandial dyslipidemia in insulin resistance: Mechanisms and role of intestinal insulin sensitivity

(2008) Joanne Hsieh et al.   ATHEROSCLEROSIS SUPPLEMENTS

Liver X receptor modulators: Effects on lipid metabolism and potential use in the treatment of atherosclerosis

(2008) C. Fiévet et al.   BIOCHEMICAL PHARMACOLOGY

Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8

(2008) Laura Calpe-Berdiel et al.   JOURNAL OF LIPID RESEARCH

The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis

(2008) Daniel J. Rader et al.   JOURNAL OF LIPID RESEARCH

Indazole-Based Liver X Receptor (LXR) Modulators with Maintained Atherosclerotic Lesion Reduction Activity but Diminished Stimulation of Hepatic Triglyceride Synthesis∥

(2008) Jay Wrobel et al.   JOURNAL OF MEDICINAL CHEMISTRY